Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study

Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study

Nafamostat mesylate may be effective against coronavirus disease 2019 (COVID-19). However, it is not known whether its use is associated with reduced in-hospital mortality in clinical practice. We conducted a retrospective observational study to evaluate the effect of nafamostat mesylate in patients...

Full description

Bibliographic Details
Main Authors: Ryota Inokuchi, Toshiki Kuno, Jun Komiyama, Kazuaki Uda, Yoshihisa Miyamoto, Yuta Taniguchi, Toshikazu Abe, Miho Ishimaru, Motohiko Adomi, Nanako Tamiya, Masao Iwagami
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
coronavirus disease 2019
in-hospital mortality
nafamostat mesylate
Online Access:https://www.mdpi.com/2077-0383/11/1/116

Internet

https://www.mdpi.com/2077-0383/11/1/116

Similar Items